Clinical Trial Update: Genomic Landscape of Ceritinib

View source ↗

Summary

Clinical trial update indicates the study evaluating the genomic landscape of ceritinib in non-small cell lung cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Zykadia (ceritinib)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Carcinoma, Non-Small-Cell Lung, Non-small Lung Cancer | Status: TERMINATED